{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:33:31Z","timestamp":1780083211242,"version":"3.54.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Shaanxi Province Key Research and Development Projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejphar.2024.177204","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:44:23Z","timestamp":1733939063000},"page":"177204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Type I interferon-stimulated genes predict clinical response to belimumab in systemic lupus erythematosus"],"prefix":"10.1016","volume":"987","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7642-7316","authenticated-orcid":false,"given":"Hanchao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bomiao","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2695-246X","authenticated-orcid":false,"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1335-7522","authenticated-orcid":false,"given":"Lingfei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3609-8479","authenticated-orcid":false,"given":"Xinyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177204_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001032","article-title":"Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature","volume":"10","author":"Arnaud","year":"2023","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ejphar.2024.177204_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","article-title":"Personalized immunomonitoring uncovers molecular networks that stratify lupus patients","volume":"165","author":"Banchereau","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.177204_bib3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1191\/096120300674499064","article-title":"Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies","volume":"9","author":"Bengtsson","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.ejphar.2024.177204_bib4","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1177\/0961203319869468","article-title":"Belimumab alters transitional B-cell subset proportions in patients with stable systemic lupus erythematosus","volume":"28","author":"Benitez","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.ejphar.2024.177204_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2024.177204_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.autrev.2017.11.009","article-title":"Targeting interferons and their pathways in systemic lupus erythematosus","volume":"17","author":"Chasset","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejphar.2024.177204_bib7","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1093\/rheumatology\/keaa167","article-title":"Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers","volume":"59","author":"Chasset","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejphar.2024.177204_bib8","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.38628","article-title":"Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures","volume":"66","author":"Chiche","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejphar.2024.177204_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/08916930310001625952","article-title":"Microarray analysis of interferon-regulated genes in SLE","volume":"36","author":"Crow","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejphar.2024.177204_bib10","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","article-title":"Novel paradigms in systemic lupus erythematosus","volume":"393","author":"Dorner","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2024.177204_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.coi.2012.08.004","article-title":"Complement, interferon and lupus","volume":"24","author":"Elkon","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejphar.2024.177204_bib12","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2024.177204_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejphar.2024.177204_bib14","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2024.177204_bib15","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/art.40439","article-title":"Long-Term safety and efficacy of belimumab in patients with systemic lupus erythematosus: a continuation of a seventy-six-week phase III parent study in the United States","volume":"70","author":"Furie","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejphar.2024.177204_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155633","article-title":"Abnormalities of the type I interferon signaling pathway in lupus autoimmunity","volume":"146","author":"Gallucci","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.ejphar.2024.177204_bib17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2024.177204_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imr.12815","article-title":"Autoreactive B cells in SLE, villains or innocent bystanders?","volume":"292","author":"Hamilton","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2024.177204_bib19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/rheumatology\/keaa609","article-title":"Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family","volume":"60","author":"Haque","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejphar.2024.177204_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni.3326","article-title":"Self-reactive IgE exacerbates interferon responses associated with autoimmunity","volume":"17","author":"Henault","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2024.177204_bib21","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/rheumatology\/keaa114","article-title":"Proportions of B-cell subsets are altered in incomplete systemic lupus erythematosus and correlate with interferon score and IgG levels","volume":"59","author":"Henning","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejphar.2024.177204_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122525","article-title":"Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients","volume":"3","author":"Huang","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2024.177204_bib23","article-title":"Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus","volume":"9","author":"Kaan","year":"2024","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.ejphar.2024.177204_bib24","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.4049\/jimmunol.1003468","article-title":"IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity","volume":"187","author":"Kenyon","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2024.177204_bib25","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2024.177204_bib26","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1002\/art.20798","article-title":"Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus","volume":"50","author":"Kirou","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2024.177204_bib27","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2024.177204_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fimmu.2013.00306","article-title":"IFNalpha inducible models of murine SLE","volume":"4","author":"Liu","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2024.177204_bib29","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2024.177204_bib30","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1038\/s41467-020-19918-z","article-title":"Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity","volume":"11","author":"Psarras","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2024.177204_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","article-title":"IgG fc receptors","volume":"19","author":"Ravetch","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2024.177204_bib32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.21571","article-title":"The type I interferon system in systemic lupus erythematosus","volume":"54","author":"Ronnblom","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2024.177204_bib33","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1084\/jem.20091087","article-title":"Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation","volume":"206","author":"Seifert","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2024.177204_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.trsl.2021.07.006","article-title":"Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus. A systematic review of cross-sectional studies","volume":"238","author":"Siddiqi","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejphar.2024.177204_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4049\/jimmunol.1101686","article-title":"Myeloid dendritic cells from B6.NZM Sle1\/Sle2\/Sle3 lupus-prone mice express an IFN signature that precedes disease onset","volume":"189","author":"Sriram","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2024.177204_bib36","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.34400","article-title":"Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus","volume":"64","author":"Stohl","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2024.177204_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000499","article-title":"Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE","volume":"9","author":"Struemper","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ejphar.2024.177204_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/annrheumdis-2021-221464","article-title":"Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus","volume":"81","author":"Takeshima","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2024.177204_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0000000000000524","article-title":"An update on the role of type I interferons in systemic lupus erythematosus and Sjogren's syndrome","volume":"30","author":"Thorlacius","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.ejphar.2024.177204_bib40","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ejphar.2024.177204_bib41","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/j.2326-5205.1989.tb00024.x","article-title":"MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus","volume":"32","author":"von Wussow","year":"1989","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2024.177204_bib42","article-title":"The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177204_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-02177-0","article-title":"The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis","volume":"22","author":"Wilkinson","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2024.177204_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001669","article-title":"Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years","volume":"8","author":"Zhang","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.ejphar.2024.177204_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109166","article-title":"Peripheral immunophenotypes associated with the flare in the systemic lupus erythematosus patients with low disease activity state","volume":"245","author":"Zheng","year":"2022","journal-title":"Clin. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992400894X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992400894X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T17:07:59Z","timestamp":1735319279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992400894X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"alternative-id":["S001429992400894X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177204","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I interferon-stimulated genes predict clinical response to belimumab in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177204"}}